Aquestive Therapeutics Inc (AQST)

Oct 10, 2025

Aquestive Therapeutics (AQST) Surges 7.9%: Is This an Indication of Further Gains? - Yahoo Finance

Oct 10, 2025

Oct 10, 2025

Is Aquestive Therapeutics Inc. reversing from oversold territoryJuly 2025 EndofMonth & Reliable Trade Execution Plans - newser.com

Oct 10, 2025

Oct 10, 2025

How to build a dashboard for Aquestive Therapeutics Inc. stockStock Surge & Momentum Based Trading Signals - newser.com

Oct 10, 2025

Oct 09, 2025

Weiss Ratings Reiterates Sell (D-) Rating for Aquestive Therapeutics (NASDAQ:AQST) - MarketBeat

Oct 09, 2025

Oct 09, 2025

JMP Securities Maintains Aquestive Therapeutics (AQST) Market Outperform Recommendation - Nasdaq

Oct 09, 2025

Oct 09, 2025

What high frequency data says about Aquestive Therapeutics Inc.July 2025 Trends & Free Weekly Chart Analysis and Trade Guides - newser.com

Oct 09, 2025

Oct 08, 2025

Aquestive Therapeutics Broadens Patent Estate for Anaphylm™ - GlobeNewswire

Oct 08, 2025

Oct 08, 2025

Aquestive Therapeutics Shares Rise After Obtaining 2 New US Patents for Anaphylm Sublingual Film - MarketScreener

Oct 08, 2025

Oct 08, 2025

Aquestive Therapeutics Obtains 2 New US Patents for Anaphylm Sublingual Film - MarketScreener

Oct 08, 2025

Oct 08, 2025

Aquestive receives two new patents for oral anaphylaxis treatment By Investing.com - Investing.com Nigeria

Oct 08, 2025

Oct 08, 2025

Aquestive receives two new patents for oral anaphylaxis treatment - Investing.com India

Oct 08, 2025

Oct 08, 2025

Aquestive Therapeutics Broadens Patent Estate for Anaphylm™ - GlobeNewswire Inc.

Oct 08, 2025

Oct 06, 2025

Signal strength of Aquestive Therapeutics Inc. stock in tech scanners2025 Technical Patterns & Safe Capital Growth Trade Ideas - newser.com

Oct 06, 2025

Oct 06, 2025

Why Aquestive Therapeutics Inc. stock is seen as undervaluedWeekly Profit Summary & Community Verified Watchlist Alerts - newser.com

Oct 06, 2025

Oct 06, 2025

Custom watchlist performance reports with Aquestive Therapeutics Inc.2025 Dividend Review & Free Expert Verified Stock Movement Alerts - newser.com

Oct 06, 2025

Oct 06, 2025

Statistical indicators supporting Aquestive Therapeutics Inc.’s strengthTrade Analysis Summary & Comprehensive Market Scan Insights - newser.com

Oct 06, 2025

Oct 05, 2025

Advanced analytics toolkit walkthrough for Aquestive Therapeutics Inc.Portfolio Profit Report & AI Forecast for Swing Trade Picks - newser.com

Oct 05, 2025

Oct 01, 2025

Aquestive Therapeutics Advances Anaphylm Clinical Development - TipRanks

Oct 01, 2025

Sep 29, 2025

Aquestive Therapeutics SVP sells $63,000 in shares By Investing.com - Investing.com Nigeria

Sep 29, 2025

Sep 29, 2025

Aquestive Therapeutics CEO Barber sells $551k in shares By Investing.com - Investing.com Canada

Sep 29, 2025

Sep 29, 2025

Aquestive Therapeutics (NASDAQ:AQST) CEO Sells $550,798.29 in Stock - MarketBeat

Sep 29, 2025

Sep 29, 2025

Peter Boyd Sells 10,000 Shares of Aquestive Therapeutics (NASDAQ:AQST) Stock - MarketBeat

Sep 29, 2025

Sep 29, 2025

Aquestive Therapeutics (NASDAQ:AQST) Trading Down 5.3% After Insider Selling - MarketBeat

Sep 29, 2025

Sep 29, 2025

Aquestive Therapeutics SVP sells $63,000 in shares - Investing.com

Sep 29, 2025

Sep 29, 2025

Aquestive Therapeutics Hits New 52-Week High of $6.00, Up 105.43% - Markets Mojo

Sep 29, 2025

Sep 29, 2025

What drives Aquestive Therapeutics Inc stock priceAI-Driven Market Analysis & Master Stock Selection - earlytimes.in

Sep 29, 2025

Sep 29, 2025

Aquestive Therapeutics Hits New 52-Week High of $6.43 - Markets Mojo

Sep 29, 2025

Sep 29, 2025

Is Aquestive Therapeutics Inc a good long term investmentSmall Cap Stock Opportunities & Collaborate and Win Together - earlytimes.in

Sep 29, 2025

Sep 28, 2025

What analysts say about Aquestive Therapeutics Inc stockVolume Weighted Average Price & See Risk Factors Before Making Any Move - earlytimes.in

Sep 28, 2025

Sep 28, 2025

Published on: 2025-09-28 19:22:53 - earlytimes.in

Sep 28, 2025

Sep 28, 2025

Aquestive Therapeutics Sees Stock Surge Following FDA Approval News - timothysykes.com

Sep 28, 2025

Sep 27, 2025

AQST Stock Up as FDA Skips Advisory Meeting to Discuss Anaphylm NDA - MSN

Sep 27, 2025